StonvexLoading…
StonvexStonvexStonvexCore line items from GOOD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $43.41M | $41.91M | $161.34M | $117.88M | $77.03M |
Operating Income | Not available | Not available | Not available | Not available | Not available |
Net Income | Not available | $6.97M | $19.29M | $13.90M | $9.77M |
EPS (Diluted) | $0.03 | $0.08 | $0.14 | $0.09 | $0.07 |
Total Assets | Not available | $1.23B | $1.25B | $1.27B | $1.21B |
Total Liabilities | Not available | $897.36M | $905.00M | $910.00M | $862.63M |
Cash & Equivalents | Not available | $7.96M | $10.81M | $18.40M | $11.66M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 48.41M | 48.41M | 48.40M | 46.51M |